Drug
Who makes pazopanib hydrochloride?
4 companies list pazopanib hydrochloride as a human prescription drug, including under the names VOTRIENT. Forms: tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing pazopanib hydrochloride
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Novartis Pharmaceuticals CorporationSwitzerland | tablet, film coated | NDANDA022465 | 1 | 20 |
| Torrent Pharma, Inc.India | tablet, film coated | ANDAANDA219922 | 1 | 5 |
| Novugen Pharma Sdn. Bhd.Malaysia | tablet, film coated | ANDAANDA218231 | 1 | 1 |
| Novartis Pharma Produktions GmbH | tablet, film coated | DRUG FOR FURTHER PROCESSING | 1 | 0 |
Bulk ingredient listings
- CIPLA PHARMACEUTICALS LIMITEDIndia · 1 NDC
- Formosa Laboratories, Inc.Taiwan · 1 NDC
- Granules Pharmaceuticals Inc.India · 1 NDC
- Hetero Labs LimitedIndia · 1 NDC
- MSN Laboratories Private Limited,India · 1 NDC
- Medichem Manufacturing (Malta) Ltd. · 1 NDC
- Medichem SASpain · 1 NDC
- Sionc Pharmaceuticals Private LimitedIndia · 1 NDC
- ZHEJIANG LEPU PHARMACETICAL CO., LTD. · 1 NDC
Enquiry
Common questions
- Who makes pazopanib hydrochloride?
- 4 companies list pazopanib hydrochloride as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Torrent Pharma, Inc., Novugen Pharma Sdn. Bhd., Novartis Pharma Produktions GmbH. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic VOTRIENT?
- 2 companies list pazopanib hydrochloride under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies pazopanib hydrochloride active ingredient?
- 9 companies list pazopanib hydrochloride as a bulk ingredient, including CIPLA PHARMACEUTICALS LIMITED, Formosa Laboratories, Inc., Granules Pharmaceuticals Inc., Hetero Labs Limited.